Semaglutide is making waves as a groundbreaking treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and reducing glucagon production.
, Additionally, , semaglutide exhibits potential app